The Inhibition of SARS-CoV-2 and the Modulation of Inflammatory Responses by the Extract of Lactobacillus sakei Probio65

In the three years since the first outbreak of COVID-19 in 2019, the SARS-CoV-2 virus has continued to be prevalent in our community. It is believed that the virus will remain present, and be transmitted at a predictable rate, turning endemic. A major challenge that leads to this is the constant yet...

Descripción completa

Detalles Bibliográficos
Autores principales: Rather, Irfan A., Lew, Lee-Ching, Kamli, Majid Rasool, Hakeem, Khalid Rehman, Sabir, Jamal S. M., Park, Yong-Ha, Hor, Yan-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787410/
https://www.ncbi.nlm.nih.gov/pubmed/36560517
http://dx.doi.org/10.3390/vaccines10122106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787410/
https://www.ncbi.nlm.nih.gov/pubmed/36560517
http://dx.doi.org/10.3390/vaccines10122106

Ejemplares similares